Lipopolysaccharide Changes in Impermeability-Type Aminoglycoside Resistance in Pseudomonas Aeruginosa.

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.26.2.250
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Determinants of Intrinsic Aminoglycoside Resistance in Pseudomonas Aeruginosa

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2012English

Novel Genetic Determinants of Low-Level Aminoglycoside Resistance in Pseudomonas Aeruginosa

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2008English

R Factor-Mediated Aminoglycoside Antibiotic Resistance in Pseudomonas Aeruginosa: A New Aminoglycoside 6'-N-Acetyltransferase

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1975English

Risk Factors for Acquisition of Fluoroquinolone or Aminoglycoside Resistance in Addition to Carbapenem Resistance in Pseudomonas Aeruginosa

Open Microbiology Journal
ImmunologyMicrobiology
2018English

Aminoglycoside 3'-Phosphotransferases I and II in Pseudomonas Aeruginosa.

Journal of Antibiotics
Drug DiscoveryPharmacology
1975English

nfxC-type Quinolone Resistance in a Clinical Isolate of Pseudomonas Aeruginosa

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1995English

Hospital Pseudomonas Aeruginosa: Surveillance of Resistance to Gentamicin and Transfer of Aminoglycoside R Factor

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1975English

Presence or Absence of Lipopolysaccharide O Antigens Affects Type III Secretion by Pseudomonas Aeruginosa

Journal of Bacteriology
MicrobiologyMolecular Biology
2007English

Carbapenem Resistance Mechanisms in Pseudomonas Aeruginosa Clinical Isolates

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy